A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
about
Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLExposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationHost response mechanisms in periodontal diseasesImpact of inflammation on the osteoblast in rheumatic diseasesProteomics approaches for the studies of bone metabolismMCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formationAnabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblastsExome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes.Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionEvaluation of Osteogenesis and Angiogenesis of Icariin in Local Controlled Release and Systemic Delivery for Calvarial Defect in Ovariectomized Rats.TNF alpha and the TNF receptor superfamily: structure-function relationship(s).Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cellsRank Protein Immunolabeling during Bone-Implant Interface Healing Process.Generation and culture of osteoclasts.Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of Toll-like receptor 2 (TLR2) and TLR4.Osteoprotegerin.The hemoglobin receptor protein of porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophagesInhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclasePeroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3Glycosaminoglycans modulate RANKL-induced osteoclastogenesisFunctional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.Skeletal health of children and adolescents with inflammatory bowel disease.Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signalingIdentification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL geneFibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in miceDeficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models."Culture shock" from the bone cell's perspective: emulating physiological conditions for mechanobiological investigations.Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort.Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts.Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast FunctionmiR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathwayRank ligand as a target in musculoskeletal neoplasms.Rheumatic diseases: the effects of inflammation on bone.Age and motor score predict osteoprotegerin level in chronic spinal cord injury.The role of T cells in periodontal disease: homeostasis and autoimmunity.Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance.Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways.
P2860
Q24632345-10561D09-0BBD-4DCC-B466-360836DD103DQ24796088-F0452E69-B0BA-4EC2-A04E-B88C51C54645Q26801846-EF30E0E3-256D-4803-A505-629BCF7759ADQ26829246-917B9F8C-ECE3-46F2-895B-561DA560DBA8Q27016578-E205C0BD-8FF4-463D-98B7-3661DC1AF472Q28236005-02EB4E50-B737-409D-81F8-0DB95715FFB9Q28568727-4C2D4B87-D009-40DE-BE70-41224E36F1F0Q30455193-28C4F6A3-B071-4846-8CF0-BA23216785D1Q33195270-A0120DBE-29C9-4ECE-8789-3E0CC50BA966Q33232238-AF6DFA6D-7FED-4E83-9259-78D305115DA7Q33886695-819255B7-1697-4EFD-911D-5AD8F3DDA7ACQ33894857-3BAB3982-B8FA-4DC2-BAB5-2C2427412106Q33909217-FA5BB52B-5FEF-4F00-AF19-D08845AEB3A6Q34022425-961BFBFD-56B8-473B-A9AA-137C74E0A2C2Q34034613-16CC9B74-100C-47AC-A7BA-18B7F677036BQ34171862-192D591F-ECA7-44F0-BD84-0AA3F5201C29Q34298604-39D6B2CE-3B54-4B40-BAF5-111E2FCFAF29Q34560598-B20773C5-4629-4C79-B566-45CC8407E588Q34601780-5F2AEB35-5C4E-43A5-B7CA-CC0B2E9E5899Q34605943-2B6D46C1-88C1-4534-B3EC-BDD779C8FE9CQ34729815-56AA58D6-96AE-4291-9938-E0B74FE6C302Q34982927-EF37AF02-6DD0-4F15-9B07-D790415EFD3CQ35008871-AB020C40-72E4-49A4-9E81-635E3711AB0FQ35065044-3D5EC8AB-0468-476C-93DF-29F5393D6300Q35184303-DC011C44-0E2B-42DD-AA34-DB8C6916BEFFQ35511177-0DA9DAB7-A8ED-43EE-A3FF-98FB07FE0098Q35757879-95C5F3DD-6694-4BE6-96A6-152E09DCB1E0Q35760681-C8ED3087-7FCF-4217-954A-EF4D1998C080Q35792117-899E4342-8488-4F48-8D1E-3DE275969EAAQ35866181-B2CA76B0-AD3B-4983-A17C-E427026FACFCQ35899487-9B29415E-F930-414F-8DD1-8F6E4B442885Q35923076-F5C0CEC0-E360-41C6-ABB9-4A4E182C0E7BQ35953074-5EA52126-5FAC-4BE3-AAEB-58C225F62878Q36192032-64AD0D95-AEF5-409C-800F-A1FCFCD2128EQ36240919-AF369724-E102-4E0B-A6C6-EE087C436D7AQ36324975-AF21AA19-FA9F-4C6C-BDB4-7C30DB25C253Q36628354-C463E2B1-CA4E-4EFF-9AA8-FB4F9B7B67F3Q36703937-69818D72-605B-43BD-964A-2688735F51B5Q36774804-FCF73E7B-5188-4859-B42C-BF11F977EB33Q37297601-C9716D08-BB36-4C59-AD94-600EA42F5C4F
P2860
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A new member of tumor necrosis ...... differentiation and function.
@ast
A new member of tumor necrosis ...... differentiation and function.
@en
A new member of tumor necrosis ...... differentiation and function.
@nl
type
label
A new member of tumor necrosis ...... differentiation and function.
@ast
A new member of tumor necrosis ...... differentiation and function.
@en
A new member of tumor necrosis ...... differentiation and function.
@nl
prefLabel
A new member of tumor necrosis ...... differentiation and function.
@ast
A new member of tumor necrosis ...... differentiation and function.
@en
A new member of tumor necrosis ...... differentiation and function.
@nl
P2093
P356
P1476
A new member of tumor necrosis ...... differentiation and function.
@en
P2093
P304
P356
10.1006/BBRC.1999.0252
P407
P577
1999-03-01T00:00:00Z